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Ethical Questions on the Use
of Magnetic Field Reports
Results from National Toxicology Program
draft reports on carcinogenesis and promo-
tion of 60-Hz magnetic fields (1,2) are a
mixed bag of apparent effects in some cases
and no effects in other cases. The studies were
carried out, apparently, with the intent to
provide information that can be used in mak-
ing health policy for humans. I contend that
these studies cannot be used for this purpose
because oftwo implicit assumptions thatwere
madewhen thestudies were beingdesigned.
First, it was assumed that the relevant
magnetic field parameter for inducing biologi-
cal effects is a pure 60-Hz sine-wave, and such
was used. But the public is exposed to some-
thingverydifferent, as the authors admit (1):
While power line magnetic field exposures
are predominantly sine-wave fields, residential
and occupational exposures may indude square
waves, sawtooth waves, and other wave forms.
Harmonics (120 Hz, 180 Hz, etc.) may also be
found. Further, as appliances are switched on
and off, spikes or transients in fields may occur.
It is not feasible to evaluate all possible variables
in large animal studies. Therefore, this study
used linearly polarized, pure sine-wave exposures
at 60 Hz, with the fields turned onwhen the sine
wave was at zero amplitude and gradually
increased overseven to nine cycles (between 0.11
and 0.15 seconds) to full intensity, and similarly
gradually decreased to avoid transients. The
NIEHS studies evaluate the predominant com-
ponent (60-Hz sine-wave magnetic fields) with-
out all the complexities of the exposures that
occur in residential and occupational settings.
Biological theory, as well as substantial
published data, indicates that the field charac-
teristics which people are actually exposed to,
and which the authors eliminated from their
experiments, are the effective agents (3).
Thus, ifone wants to use the results ofthese
studies in setting health policy for people
exposed to power line fields, one must first
prove that a pure sine-wave field is the rele-
vant parameter forinducing biological effects.
The second implicit assumption made by
theauthors was thatmagneticfields are an alien
substance, suchasarsenic, etc. Thus, theysetup
theexperiments usingatoxicology model-in a
dose-response format. In fact, electrical and
magnetic fields are not alien substances; rather,
they are fundamental in the functioning ofliv-
ing organisms. I have addressed this matter in
detail in several publications (3,4). Thus, ifone
wants to use the results ofthese studies in set-
ting health policy for people exposed to power
linefields, onemustfirstprove thatatoxicology
modelisappropriate.
Although the technology in these experi-
ments may be fine, it would not be ethical to
use the results in the formulation of health
policy for the human population without
first proving that the implicit assumptions
that were made are true. These comments
also apply to other recent studies, such as the
study byMandeville et al. (5).
Allan H. Frey
Randomline, Inc.
Potomac, Maryland
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Response: Magnetic Field
Reports
The logic ofAllan Frey's first criticism ("First,
it was assumed that the relevant magnetic field
parameter forinducingbiological effects....") is
undear. By citing remarks ofthe authors (1),
he is acknowledging that the predominant
component ofenvironmental fields is the 60-
Hz component (60 Hz in the United States
and 50 Hz in Europe), yet he is being critical
ofits use as the candidate exposure parameter
in the toxicology and carcinogenesis studies,
which is puzzling. His reasons for dismissing
the 60-Hz component as the active agent are
"Biological theory as well as substantial pub-
lished data....` indicate that other attributes of
the magnetic field are the "effective agent,"
and he cites a reference ofhis own (4) in sup-
port ofhis position. Apparently Frey has not
read the breakout group report from the first
RAPID Program Science Review Symposium
on theoretical mechanisms and in vitro find-
ings (3), which considered mechanism theories
for EMF biological effects. The report (3),
reflecting the views of experts in 1997, indi-
cates that the biological effects that have been
reported in the literature are "not expected
based on known biophysical mechanisms."
Therefore, it is notclearwhat "biological theo-
ry" Frey is referring to. Frey suggests that
"properly tuned" magnetic fields should be
used for exposure purposes (4). The main
magnetic fields of interest have been those of
power frequencies; however, in the EMF
RAPID program, other magnetic field fre-
quencies arebeingconsidered.
In regard to the "substantial published
data" that supports Allan Frey's first criti-
cism, he has failed to note that there has been
no independent replication of the biological
effects reported in the archival literature. The
four EMF Regional Exposure Facilities (at
the Food and Drug Administration in
Rockville, MD; the National Institute for
Occupational Safety and Health (NIOSH) in
Cincinnati, OH; the Oak Ridge National
Laboratories in Oak Ridge, TN; and the
Pacific Northwest Laboratories, in Richland,
WA) supported by the EMF RAPID pro-
gram and the Department ofEnergy (DOE),
where all studies are done in a blind fashion
including sham/sham controls, have failed to
replicate a single in vitroeffect after 3 years of
effort. Only recently have there been reports
ofreplication ofan in vitro study (conducted
elsewhere and yet to be published). The fail-
ure in the United States (5) to replicate the
cancer promotion results that were first
observed in Germany using "pure sine-wave"
power frequency magnetic fields is a recent
example in which the replication effort was
unsuccessful. Because the original promotion
study employed pure sine-wave magnetic
fields and reported adverse biological effects,
the same purely sinusoidal fields had to be
used in the replication effort. Why Frey is
critical of the use of sine-wave fields in the
promotion replication study is unclear.
Frey's viewthat "one must first prove that a
pure sine-wave field is the relevant parameter
for inducingbiological effects" is betterdirected
at the othercandidate exposure parameters. For
example, transients (spikes) in the magnetic
field have been suggested as a candidate expo-
sureparameter. In 1991,when theprotocols for
the toxicology study were being developed,
there were no published data or theory regard-
ing transients. It was not until September 1994
at the DOE/NIOSH workshop on EMF expo-
sure assessment thatfast transientswere suggest-
ed as a candidate exposure parameter. In con-
sidering other candidate exposure parameters,
the NIEHS, through the EMF RAPID pro-
gram, supported an evaluation ofthe third and
fifth harmonic, transients, and intermittent
field exposures in rats using pineal and serum
nocturnal melatonin levels, pineal serotonin N-
acetyltransferase activity, and ornithine decar-
boxylase levels in various tissues as parameters
ofa biological effect. These studies have been
completed and the results were presented at the
third Science Review Symposia, held in
Phoenix, Arizona 5-9 April 1998.
GaryABoorman
National Institute ofEnvironmental
Health Sciences
Research Triangle Park, NC
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The Importance of Protocol
Design and Data Reporting to
Research on Endocrine
Disruption
Several recent articles have discussed the
doubts expressed by some scientists regarding
the validity of endocrine disruption studies
conducted by industrial scientists or spon-
sored by the chemical industry (1-3). The
last of these articles (3) recounted personal
attacks made on the integrity ofStephen Safe
ofTexas A&M University.
It is in the nature ofany new branch of
toxicology that, at least initially, adverse
effects may be discovered for chemicals by
those academic laboratories working in the
new area. The chemical industry is then left
to confirm and extend the findings ofothers.
Such confirmatory studies are usually neces-
sary because the initial publications often
describe the results oflimited or unreplicated
experiments (4). The articles mentioned
above (1-3) concerned the prospect that
repeat studies conducted by or sponsored by
the chemical industry are designed in order
not to confirm the original observation. We
wish to discuss the complementary concern
that many new findings in this area are either
inadequately described or are based on data
derived using inadequate test protocols. This
makes it difficult to conduct faithful repeat
experiments, however well-motivated the
responsible scientists are.
We recently decided to confirm and
extend adverse endocrine toxicities reported
for nonylphenol (NP) and bisphenol-A
(BPA). For both ofthese chemicals, we expe-
rienced problems when attempting to design
repeat experiments due to inadequacies ofthe
original publications. These inadequacies may
seem to be relatively minor, but when the
outcomes ofthe repeat experiments are likely
to bechallenged, theybecome important.
Three influential papers using the Noble
rat have been published by Colerangle and
Roy over the past 4 years (5-7). The papers in
question report the results of implanting the
estrogens estrone, diethylstilbestrol (DES),
NP, or BPA into Noble rats and monitoring
the consequent changes in cell growth in the
mammary gland. Either pellets or mini-
pumps were used to deliver the test chemicals
over 11 days. In each case growth of the
mammary gland was reported. A significant
aspect ofthese results is that estrogenic effects
were found for NP and BPA at much lower
dose levels than would have been expected
based on the results of earlier studies (8-11),
in particular, rat uterotrophic assays conduct-
ed using three dailyadministrations ofthe test
chemicals. To resolve the uncertainties created
by this apparent difference in assay sensitivi-
ties, we embarked on full repeats ofthe DES
and NP Noble rat mammary gland assays
(5-7). We also conducted rat uterotrophic
assays utilizing the dosing protocol used by
Colerangle and Roy [the test compound
administered over 11 days via subcutaneously
implanted mini-pumps (5-7)] and multiple
strains ofrats, including the Noble strain.
The following inadequacies of the three
published studies in Noble rats have compli-
cated their interpretation and the design of
our own studies (5-7).
In the first study (5), DES was adminis-
tered over 11 days as a subcutaneously
implanted pellet. Cell labeling indices and
growth fractions ofmammarygland cells were
determined using the methods ofFoley et al.
(12). DES was reported to increase the label-
ing index from 11% (controls) to 71%.
Recalculation (12) of these indices from the
primarydata presented (5) gavevalues of11%
and 21% for controls and DES, respectively.
Likewise, the growth fractions were reported
to be 21% for controls and 158% for the
DES animals; recalculation (12) from the pri-
mary data presented (5) gave values of 21%
and 47%, respectively. The estrone figures
were also in error. These errors, which have
not been formally corrected by the authors,
make it difficult to be certain of the magni-
tude of the effects expected in our repeat
experiments. Subsequent data from these
authors (6,7) appear to have been correctly
calculated based on cell number estimates
derived from the bar charts presented.
In the second and third papers (6,7), the
activities of NP and BPA in the mammary
gland ofNoble rats were compared to that of
DES. DES was shown as a positive control
agent in both of these papers, and in each
case the test data were identical to those
reported to the original study (5), including
use of the incorrect labeling indices and
growth fractions. The wrong impression was
thereby given that the DES study had been
replicated three times. Further, in the BPA
paper (7), the DES is described as being
administered via a mini-pump, whereas in
the initial paper (5) it is reported to have
been given as a pellet. No experimental
details were provided for the administration
of DES in the NP paper (6). Thus, after
three separate publications, the test data for
DES have apparentlyyet to be replicated.
Despite being published separately and a
year apart, the vehicle control data for the
NP (6) and the BPA (7) studies are the same
in each paper and different from those in the
original study (5). Either the data for NP and
BPA were derived from a single study that
was then published in two isolated parts or a
vehicle control group was absent from one of
the two studies (6,7). This created an unac-
ceptable level ofuncertainty.
Thus, while attempting to repeat these
significant new findings in the Noble rat, we
were presented with uncertainties in the orig-
inal papers that could have been regarded as
intentional had they occurred in our own
(industrial) studies.
Nagel et al. (13) reported that BPA
increased the weight of the prostate gland in
mature CF-1 mice exposed in utero. In a sub-
sequent paper from the same laboratory, vom
Saal et al. (14) reported the induction ofsimi-
lar effects by DES. When designing a repeat
ofthe CF-1 mouse experiment with BPA, we
decided to include DES as a positive control
chemical, despite the absence ofsuch a con-
trol in the original BPA study (13). However,
we were presented with a problem: the BPA
animals described by Nagel et al. (13) were
terminated at 6 months and the DES animals
described by vom Saal et al. (14) were termi-
nated at 8 months. No explanation for this
difference in test protocol was given. It was
therefore impossible to mount a faithful con-
current report of the BPA and DES experi-
ments; thus, we decided to terminate both of
our groups at 6 months. However, that means
that we will not have faithfully repeated the
original study on DES.
Another aspect of the study by Nagel et
al. (13) caused us concern. In that study, two
control groups were used: a vehicle control
group and a group of animals that were not
handled throughout the study. It was stated
(13) that these two control groups gave simi-
lar data (not shown) and that they were
therefore combined into a single, larger con-
trol group and used as such for the subse-
quent statistical analysis ofthe BPA test data.
That represents bad statistical practice. We
decided to include two such control groups
in our own experiment and to maintain their
separate identities during the statistical analy-
sis ofour data. Each ofthese small changes in
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